RG

Raju Gopagoni

Active Director Director DIN 10789276
DIN 10789276 First appointment Sep 2024 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2024
Shareholding value •••• Premium profile

About Raju Gopagoni

Data last updated:

Raju Gopagoni is a Director at Velchi Pharma Private Limited (since 2024). The company operates in Pharma. Velchi Pharma Private Limited reported revenue of ₹47.2 Lakh (FY 2025).

DIN 10789276
Primary Designation Director
Industry Pharma
First Appointment 26 Sep 2024
Oldest Company Age 2 yrs
Largest company Velchi Pharma Private Limited · ₹47.2 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Velchi Pharma Private Limited U46497TS2024PTC189655
Director26 Sep 20242024₹47.2 Lakh (FY 2025)Active

Board colleagues of Raju Gopagoni

NameDINCompanyDesignation
Shivakoti Ravi09111653Velchi Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Velchi Pharma Private Limited
Premium access

Shareholding and investment profile for Raju Gopagoni

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Raju Gopagoni

Raju Gopagoni currently holds 1 directorship: Velchi Pharma Private Limited (Director, since 26 Sep 2024, revenue ₹47.2 Lakh (FY 2025)).

Raju Gopagoni was first appointed on 26 Sep 2024 as Director at Velchi Pharma Private Limited.

The current boards of Raju Gopagoni's companies include Shivakoti Ravi (Velchi Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available